相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells
Mohamed A. Ragheb et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)
Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
Jonggi Choi et al.
HEPATOLOGY (2021)
Molecular signatures identified by integrating gene expression and methylation in non-seminoma and seminoma of testicular germ cell tumours
Saurav Mallik et al.
EPIGENETICS (2021)
An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in human gastric cancer
Mahnaz Azimi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Hypoxia-Induced Suppression of Alternative Splicing of MBD2 Promotes Breast Cancer Metastasis via Activation of FZD1
Zhaoji Liu et al.
CANCER RESEARCH (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Nomograms based on clinicopathological factors and inflammatory indicators for prediction of early and late recurrence of hepatocellular carcinoma after surgical resection for patients with chronic hepatitis B
Tianxing Dai et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Epigenetic dysregulation of Mdr1b in the blood-testis barrier contributes to dyszoospermia in mice exposed to cadmium
Yu Fang et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2020)
Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma
Jin-Yu Sun et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Assessment of lenvatinib treatment for unresectable hepatocellular carcinoma with liver cirrhosis
Shohei Komatsu et al.
HPB (2020)
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
Xiao-Yong Huang et al.
MOLECULAR CANCER (2020)
The expanding regulatory mechanisms and cellular functions of circular RNAs
Ling-Ling Chen
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy
Yan Zhao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
The genetic polymorphism down-regulatingHLA-DRB1enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population
Yang Deng et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Screening and functional prediction of differentially expressed circular RNAs in human glioma of different grades
Xiuchao Geng et al.
Aging-US (2020)
Contribution of Hepatitis B Virus Infection to the Aggressiveness of Primary Liver Cancer: A Clinical Epidemiological Study in Eastern China
Fan Yang et al.
FRONTIERS IN ONCOLOGY (2019)
FGF19-FGFR4 Signaling in Hepatocellular Carcinoma
Aroosha Raja et al.
CELLS (2019)
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming
Lei Xiong et al.
NATURE COMMUNICATIONS (2019)
Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma
Jian Yu et al.
JOURNAL OF HEPATOLOGY (2018)
Mbd2 enables tumourigenesis within the intestine while preventing tumour-promoting inflammation
Stephanie May et al.
JOURNAL OF PATHOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
A &ITLIN28B&IT Tumor-Specific Transcript in Cancer
Weijie Guo et al.
CELL REPORTS (2018)
Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing
Jian Zheng et al.
PLOS ONE (2018)
CircSLC3A2 functions as an oncogenic factor in hepatocellular carcinoma by sponging miR-490-3p and regulating PPM1F expression
Hongjian Wang et al.
MOLECULAR CANCER (2018)
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening
Laura Broutier et al.
NATURE MEDICINE (2017)
Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin
Honghai Xia et al.
SCIENTIFIC REPORTS (2016)
MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3
Hui-Lai Miao et al.
HEPATOLOGY RESEARCH (2014)
Detecting and characterizing circular RNAs
William R. Jeck et al.
NATURE BIOTECHNOLOGY (2014)
Down-Regulation of eIF4GII by miR-520c-3p Represses Diffuse Large B Cell Lymphoma Development
Krystyna Mazan-Mamczarz et al.
PLOS GENETICS (2014)
Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression
X. Tan et al.
BRITISH JOURNAL OF CANCER (2013)
Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2
Barbara Stefanska et al.
CARCINOGENESIS (2013)
Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study
Jianhua Yin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
MotEvo: integrated Bayesian probabilistic methods for inferring regulatory sites and motifs on multiple alignments of DNA sequences
Phil Arnold et al.
BIOINFORMATICS (2012)
Elucidating the Mechanism of Regulation of Transforming Growth Factor β Type II Receptor Expression in Human Lung Cancer Cell Lines
Sunil K. Halder et al.
NEOPLASIA (2011)
Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells
Amandine Chatagnon et al.
CARCINOGENESIS (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins
L. Lopez-Serra et al.
ONCOGENE (2008)
分享论文
